Volastra Therapeutics
PrivateLast Round
Series B
Sep 23, 2025
Total Funding Raised
$166.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Volastra Therapeutics is a biotechnology company that develops oncology therapeutics targeting chromosomal instability to treat metastatic cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Volastra Therapeutics Comparables
Compare Volastra Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Simcere Pharmaceutical Group | 76% | |
| Apeiron Therapeutics | 74% | |
| China National Machinery Industry Corporation | 74% | |
Volastra Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 23, 2025 | ||||
| Series A | Mar 7, 2023 | ||||
| Seed | Apr 6, 2021 | ||||
| Seed | Feb 11, 2020 |
Key People
Founding team and executive leadership
Volastra Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| B Capital Group | Series B |
| ARCH Venture Partners | Seed, Series A |
| Vida Ventures | Seed, Series A |
| Droia Ventures | Seed, Series A |
| Catalio Capital Management | Seed, Series A |
| ARCH Venture Partners | Seed, Series A |
| Cornell University Office of University Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 78% MoM, reaching 4K.
- May 31, 2026
Two assets, VLS-1488 and Sovilnesib, granted designation by the FDA.
Volastra Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Volastra Therapeutics's valuation, stock price, and market status.